<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Cécile Tremblay, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Martin S Hirsch, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keri K Hall, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 29, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human herpesvirus 6 (HHV-6) was first isolated and characterized from patients with lymphoproliferative disorders [
         <a href="#rid1">
          1
         </a>
         ] and was originally named human B-lymphotropic virus. Its name was changed to human herpesvirus 6 as its tropism was further characterized [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The virology, pathogenesis, and epidemiology of HHV-6 infection will be discussed here. The clinical manifestations, diagnosis, and treatment in adults and children are presented separately; HHV-6 infection in hematopoietic cell transplant recipients is also discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/8320.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of human herpesvirus 6 infection in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5969.html" rel="external">
          "Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1226420058">
         <span class="h1">
          TAXONOMY
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 is a member of the Herpesviridae family. Its genetic and biologic similarities to human cytomegalovirus (CMV) have prompted its classification in the beta herpesvirus subfamily (genus
         <em>
          Roseolovirus
         </em>
         , along with human herpesvirus 7) [
         <a href="#rid3">
          3
         </a>
         ]. There are two HHV-6 variants, HHV-6A and HHV-6B. Based on their distinctive biological properties and genome sequences, HHV-6A and HHV-6B are classified as two distinct herpesvirus species [
         <a href="#rid4">
          4
         </a>
         ]. HHV-6A and HHV-6B also differ in epidemiology, growth properties, antigenic properties, and restriction endonuclease profiles [
         <a href="#rid5">
          5-8
         </a>
         ]. The nucleotide sequence identity between the two variants ranges from 75 to 95 percent depending upon which gene is compared.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          VIROLOGY AND PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         As with other herpes viruses, mature HHV-6 virions are double-stranded deoxyribonucleic acid (DNA) viruses, approximately 200 nm in diameter and are composed of four main structural elements: an electron-dense core, a capsid with icosahedral symmetry, a tegument, and an outer envelope.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Cell tropism
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 replicates most efficiently in vitro in activated primary T cells as well as in continuous T cell lines. However, the virus can also replicate with varying efficiency in a wide array of host cell types including monocytes/macrophages, natural killer cells, astrocytes, megakaryocytes, and glial cell lineages [
         <a href="#rid2">
          2,9-12
         </a>
         ]. HHV-6 can also be recovered in vivo from a broad range of tissues such as lymph nodes, peripheral blood mononuclear cells (PBMCs), renal tubular cells, salivary glands, and the central nervous system [
         <a href="#rid13">
          13-19
         </a>
         ]. HHV-6 has also been identified in astrocytes from gliomas, suggesting a potential role in tumorigenesis [
         <a href="#rid20">
          20,21
         </a>
         ].
        </p>
        <p>
         During acute HHV-6 infection, monocytes/macrophages harbor more replication-competent HHV-6 than CD4+ T cells [
         <a href="#rid22">
          22
         </a>
         ]. Hematopoietic differentiation can also lead to HHV-6 reactivation from infected peripheral blood progenitor cells [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Viral replication
         </span>
         <span class="headingEndMark">
          —
         </span>
         CD46, an immunomodulatory protein that is also called membrane cofactor protein, is a cellular receptor for HHV-6A and HHV-6B [
         <a href="#rid24">
          24
         </a>
         ]. The following observations have been made concerning this relationship:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Both acute infection and cell fusion mediated by HHV-6 are specifically inhibited by antibodies against CD46, while fusion can be blocked competitively by soluble CD46 [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonhuman cells that are resistant to HHV-6 fusion and entry become susceptible upon expression of recombinant human CD46 [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Three HHV-6 glycoproteins form a heterotrimeric complex on the viral envelope that is a viral ligand for human CD46 [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CD46 isoforms may affect susceptibility of T cells to infection with HHV-6A and HHV-6B [
         <a href="#rid26">
          26
         </a>
         ]. Whether binding to CD46 plays a role in the immune dysfunction observed after HHV-6 infection remains to be determined. HHV-6 downregulates interleukin (IL)-12 production [
         <a href="#rid27">
          27
         </a>
         ], an effect that may be mediated by crosslinking of CD46 [
         <a href="#rid28">
          28
         </a>
         ]. It has also been shown that HHV-6 infection results in a reduction of CD45 on the surface of infected T cells and impaired activation in response to T cell receptor stimulation [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         CD134, a member of the tumor necrosis factor (TNF) receptor superfamily, has been identified as a receptor for HHV-6B entry [
         <a href="#rid30">
          30,31
         </a>
         ]. It has been suggested that nectin-2 may act as an HHV-6B entry-mediated protein [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         U27 increases the in vitro DNA synthesis activity of HHV-6A DNA polymerase and plays an essential role in viral replication as demonstrated in a U27-deficient mutant model [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         HHV-6 integrates into the human genome and can integrate into germline cells; several different chromosomal sites of integration have been identified [
         <a href="#rid34">
          34
         </a>
         ]. Inherited chromosomally integrated HHV-6 (iciHHV-6) can cause a confusing clinical picture in the setting of allogeneic hematopoietic cell transplantation. Because patients with inherited HHV-6 have at least one copy of the viral genome in each cell of their body, they have unusually high levels of HHV-6 DNA in blood, cerebrospinal fluid, and tissues. This is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients", section on 'Detecting inherited chromosomal integration'
         </a>
         .)
        </p>
        <p>
         Mature HHV-6 virions are found within multivesicular bodies and are released from the host cell via the exosomal pathway [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Effect on the immune system
         </span>
         <span class="headingEndMark">
          —
         </span>
         CD4+ T cells constitute the major population of cells permissive to HHV-6 replication even though HHV-6 does not bind directly to the CD4 molecule [
         <a href="#rid36">
          36
         </a>
         ]. Once HHV-6 enters a permissive host cell, viral replication occurs relatively slowly. Within 24 hours after infection, the rate of cellular protein synthesis is high; by 65 hours after infection, host cell DNA synthesis is shut off and viral DNA synthesis is underway [
         <a href="#rid37">
          37
         </a>
         ]. Cytopathic effects can be seen within three to five days after infection. The net effect is a significant impairment in immune function [
         <a href="#rid27">
          27
         </a>
         ], which may be mediated in part by downregulation of cell surface CD3 expression [
         <a href="#rid38">
          38
         </a>
         ] or via induction of cytokines, such as TNF-alpha, interferon-gamma, and IL-1 beta [
         <a href="#rid39">
          39
         </a>
         ]. Other cytokines have been shown to be upregulated including the interferon-inducible CXCL11 [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         HHV-6 differentially influences the functions of naïve T cells and different subsets of memory CD4+ and CD8+ T cells, which may be due in part to differential susceptibility to HHV-6A–induced apoptosis [
         <a href="#rid41">
          41
         </a>
         ]. HHV-6 can be transmitted from monocyte-derived dendritic cells to stimulated CD4+ T cells in vitro. Thus, dendritic cells may be the first cell population targeted by HHV-6, and they could play an important role in the virus' transmission to T cells, which leads to further virus propagation [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
         HHV-6 can induce expression of a superantigen, which may lead to further dysregulation of the immune system [
         <a href="#rid43">
          43
         </a>
         ]. On the other hand, HHV-6 increases the activity of natural killer (NK) cells via activation of IL-15 [
         <a href="#rid44">
          44
         </a>
         ]. The increase in NK cell activity may represent a natural antiviral defense mechanism that promotes elimination of virus-infected cells.
        </p>
        <p>
         HHV-6 may also establish a latent state in monocytes, capable of later reactivation [
         <a href="#rid15">
          15,45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Viral genes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The genome of the U1102 strain of HHV-6A has been completely sequenced [
         <a href="#rid46">
          46,47
         </a>
         ].
        </p>
        <p>
         HHV-6 replication genes encode a number of viral proteins including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U38, a viral DNA polymerase.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U27, a polymerase accessory/processivity protein.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U41, a single-stranded DNA-binding protein.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U43, U74, U77, which are three helicase-primase proteins.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U14, the tegument protein, constitutes the viral structure and is essential for viral replication; its crystal structure has been characterized [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U94, indispensable for HHV-6 chromosomal integration [
         <a href="#rid49">
          49,50
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U14, U11, which are important for HHV-6A maturation and propagation [
         <a href="#rid51">
          51,52
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HHV-6A U4 inhibits amyloid precursor protein degradation by interacting with cullin-RING E3 ubiquitin-protein ligases [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         U12 and U51 encode putative homologues of human G-protein-coupled receptors like CCR1, CCR3, and CCR5 [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         HHV-6 also encodes three homologues of herpes simplex virus (HSV)-1 glycoproteins important in viral entry: gB [
         <a href="#rid55">
          55
         </a>
         ], gH, and gL [
         <a href="#rid46">
          46
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Pathogenesis of infection'
         </a>
         .)
        </p>
        <p>
         Another candidate for a potential receptor-binding protein is gp82-105, which is a major component of virions and is a target for neutralizing antibodies [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         HHV-6 also encodes gene products that are able to transactivate human immunodeficiency virus (HIV)-1 long terminal repeat (LTR)-directed gene expression [
         <a href="#rid57">
          57
         </a>
         ]. This is particularly relevant because both HHV-6 and HIV-1 can infect CD4+ T lymphocytes [
         <a href="#rid58">
          58
         </a>
         ] and HHV-6 induces CD4 expression in otherwise CD4-negative subpopulations of lymphocytes and natural killer cells, making them susceptible to HIV infection [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         A study analyzing complete genomes from 61 isolates of HHV-6B from patients with active infections and 64 strains of iciHHV-6B led to altered annotations for more than 10 percent of existing genes [
         <a href="#rid60">
          60
         </a>
         ]. Multiple iciHHV-6B sequences from unrelated individuals were identical. Several iciHHV-6B strains clustered with strains from recent active pediatric infection. These results are consistent with a model of intermittent de novo integration of HHV-6B into host germline cells during active infection with a large contribution of founder effect in iciHHV-6B. Integration of HHV-6B is discussed in greater detail above. (See
         <a class="local">
          'Viral replication'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 seroprevalence rates vary from 20 percent among pregnant women in Morocco [
         <a href="#rid61">
          61
         </a>
         ] to 100 percent among asymptomatic Chinese adults [
         <a href="#rid62">
          62
         </a>
         ]. In industrialized nations such as the United States and Japan, rates of seroprevalence range from 72 to 95 percent [
         <a href="#rid63">
          63,64
         </a>
         ].
        </p>
        <p>
         HHV-6 is frequently acquired by an early age. This is illustrated by the following observations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a study of 2235 infants and children under the age of three who presented to the emergency department with an acute illness, HHV-6 DNA was detected in 10 percent of infants less than one month of age, consistent with perinatal transmission, compared with 66 percent at one year  (
         <a class="graphic graphic_figure graphicRef57693" href="/z/d/graphic/57693.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid45">
          45
         </a>
         ]. The rate of seroconversion was highest between 6 and 12 months of age.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similar findings were noted in a prospective study of 277 children in which saliva was tested weekly for HHV-6 DNA with the use of polymerase chain reaction (PCR) during the first two years of life [
         <a href="#rid65">
          65
         </a>
         ]. Primary HHV-6 infection occurred in 130 children; 40 percent of infections occurred by 12 months of age and 77 percent by 24 months.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Distribution of HHV-6A and HHV-6B
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molecular techniques have been used to determine whether the distribution of the two HHV-6 species differs based upon geography. Among young children with an acute febrile illness, the proportion of cases in which HHV-6A is detected in peripheral blood mononuclear cells (PBMCs) has varied from less than 3 percent in the United States to 44 percent of infants from central Africa [
         <a href="#rid66">
          66,67
         </a>
         ].
        </p>
        <p>
         The vast majority of isolates from otherwise healthy children or adults are HHV-6B [
         <a href="#rid45">
          45
         </a>
         ]. In contrast, both HHV-6A and -6B have been recovered from PBMCs of patients who are immunocompromised or chronically ill. In one study, for example, HHV-6A was the predominant species in lymph nodes from HIV-1 infected adults [
         <a href="#rid68">
          68
         </a>
         ]. HHV-6A may also have greater neurotropism and neurovirulence [
         <a href="#rid69">
          69,70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Incubation period and transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although there are few data regarding the incubation period of HHV-6 infection, the mean incubation period is thought to be approximately 9 to 10 days [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         The most common route of HHV-6 transmission appears to be transfer via saliva from mother to infant. Early studies detected HHV-6 in the saliva of almost all subjects tested, although some of the positive results might have been due to cross-reactivity with human herpesvirus 7 [
         <a href="#rid62">
          62,72
         </a>
         ], which is shed in saliva much more frequently [
         <a href="#rid73">
          73
         </a>
         ]. The following observations have been made in later studies using PCR in healthy individuals, although cross-reactivity is still possible with some primers:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HHV-6 has been isolated from saliva in 3 to 90 percent [
         <a href="#rid14">
          14,73,74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HHV-6 has been found in 63 percent of salivary gland biopsies, which appears to act as a viral reservoir [
         <a href="#rid73">
          73
         </a>
         ]. The tonsils may be another common site of latent infection [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Perinatal transmission is also possible. Most women of reproductive age have been infected with HHV-6, as indicated by serologic testing, and approximately 2 percent of pregnant women shed low levels of virus in genital secretions [
         <a href="#rid76">
          76
         </a>
         ]. In addition, HHV-6 DNA has been detected in 41 to 44 percent of samples during pregnancy [
         <a href="#rid77">
          77
         </a>
         ] but only 1 percent of cord blood samples [
         <a href="#rid77">
          77,78
         </a>
         ].
        </p>
        <p>
         In a study cited above of infants and young children presenting with an acute febrile syndrome, HHV-6 DNA was detected in 10 percent of infants less than one month of age, a finding that is consistent with perinatal transmission [
         <a href="#rid45">
          45
         </a>
         ]. Intrauterine transmission has also been proposed in selected cases in which spontaneous abortion, fetal hydrops, and fulminant neonatal hepatitis were associated with HHV-6 infection [
         <a href="#rid79">
          79-81
         </a>
         ].
        </p>
        <p>
         The issue of congenital HHV-6 infection was addressed in a prospective study of 5638 children [
         <a href="#rid78">
          78
         </a>
         ]. Congenital HHV-6 infections occurred in 1 percent of births, similar to the rate for cytomegalovirus infection and to the rate of isolation of HHV-6 in cord blood [
         <a href="#rid77">
          77,78
         </a>
         ]. All of the children with congenital infection were asymptomatic. In contrast, postnatal infections were associated with acute febrile illness, which has also been noted by others [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6846926">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/17204.html" rel="external">
          "Patient education: Roseola (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1078564792">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Virology
         </strong>
         − Human herpesvirus 6 (HHV-6) is a member of the Herpesviridae family. Its genetic and biologic similarities to human cytomegalovirus (CMV) have prompted its classification in the beta herpesvirus subfamily (genus
         <em>
          Roseolovirus
         </em>
         , along with human herpesvirus 7). As with other herpes viruses, mature HHV-6 virions are double-stranded DNA viruses, approximately 200 nm in diameter and are composed of four main structural elements: an electron-dense core, a capsid with icosahedral symmetry, a tegument, and an outer envelope. (See
         <a class="local">
          'Virology and pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Taxonomy
         </strong>
         − Two HHV-6 species, HHV-6A and HHV-6B, differ in epidemiology, growth properties, nucleotide sequences, antigenic properties, and restriction endonuclease profiles. (See
         <a class="local">
          'Taxonomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cell tropism
         </strong>
         − HHV-6 replicates most efficiently in vitro in activated primary T cells as well as in continuous T cell lines. However, the virus can also replicate with varying efficiency in a wide array of host cell types including monocytes/macrophages, natural killer cells, astrocytes, megakaryocytes, and glial cell lineages. (See
         <a class="local">
          'Cell tropism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cellular receptor
         </strong>
         − CD46, an immunomodulatory protein that is also called membrane cofactor protein, is a cellular receptor for HHV-6A and HHV-6B. HHV-6 integrates into the human genome; seven different chromosomal sites of integration have been identified. (See
         <a class="local">
          'Viral replication'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Viral replication and effect on immune system
         </strong>
         − CD4+ T cells constitute the major population of cells permissive to HHV-6 replication even though HHV-6 does not bind directly to the CD4 molecule. Once HHV-6 enters a permissive host cell, viral replication occurs relatively slowly. Within 24 hours after infection, the rate of cellular protein synthesis is high; by 65 hours after infection, host cell DNA synthesis is shut off and viral DNA synthesis is underway. Cytopathic effects can be seen within three to five days after infection. The net effect is a significant impairment in immune function. (See
         <a class="local">
          'Effect on the immune system'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Important viral proteins
         </strong>
         − HHV-6 replication genes encode a number of viral proteins including U38, a viral DNA polymerase; U27, a polymerase accessory/processivity protein; U41, a single-stranded DNA-binding protein; and U43, U74, U77, which are three helicase-primase proteins. (See
         <a class="local">
          'Viral genes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seroprevalence
         </strong>
         − HHV-6 seroprevalence rates vary from 20 percent among pregnant women in Morocco to 100 percent among asymptomatic Chinese adults. In industrialized nations such as the United States and Japan, rates of seroprevalence range from 72 to 95 percent. HHV-6 is frequently acquired by an early age. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Predominance of HHV-6B
         </strong>
         − The vast majority of isolates from otherwise healthy children or adults are HHV-6B. In contrast, both HHV-6A and -6B have been recovered from peripheral blood mononuclear cells of patients who are immunocompromised or chronically ill. (See
         <a class="local">
          'Distribution of HHV-6A and HHV-6B'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transmission
         </strong>
         − Although there are few data regarding the incubation period of HHV-6 infection, it is thought to be approximately 9 days (range 5 to 15 days). The most common route of HHV-6 transmission appears to be transfer via saliva from mother to infant. Perinatal transmission is also possible. (See
         <a class="local">
          'Incubation period and transmission'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234:596.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ablashi DV, Salahuddin SZ, Josephs SF, et al. HBLV (or HHV-6) in human cell lines. Nature 1987; 329:207.
          </a>
         </li>
         <li class="breakAll">
          Yamanishi K, Mori Y, Pellett PE. Human herpesvirus 6 and 7. In: Fields Virology, 6th edition, Knipe DM, Howley P (Eds), Wolters Kluwer Health, Philadelphia 2013. Vol 2, p.2058.
         </li>
         <li class="breakAll">
          International Committee on Taxonomy of Viruses. ICTV Master Species List 2011. http://talk.ictvonline.org/files/ictv_documents/m/msl/4090.aspx (Accessed on June 27, 2012).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ablashi DV, Balachandran N, Josephs SF, et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991; 184:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aubin JT, Agut H, Collandre H, et al. Antigenic and genetic differentiation of the two putative types of human herpes virus 6. J Virol Methods 1993; 41:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dewhurst S, Chandran B, McIntyre K, et al. Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology 1992; 190:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Achour A, Malet I, Le Gal F, et al. Variability of gB and gH genes of human herpesvirus-6 among clinical specimens. J Med Virol 2008; 80:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cermelli C, Concari M, Carubbi F, et al. Growth of human herpesvirus 6 in HEPG2 cells. Virus Res 1996; 45:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen M, Popescu N, Woodworth C, et al. Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol 1994; 68:1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He J, McCarthy M, Zhou Y, et al. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996; 70:1296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luka J, Okano M, Thiele G. Isolation of human herpesvirus-6 from clinical specimens using human fibroblast cultures. J Clin Lab Anal 1990; 4:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine PH, Jahan N, Murari P, et al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992; 166:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cone RW, Huang ML, Ashley R, Corey L. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 1993; 31:1262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kondo K, Kondo T, Okuno T, et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991; 72 ( Pt 6):1401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okuno T, Higashi K, Shiraki K, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990; 49:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krueger GR, Wassermann K, De Clerck LS, et al. Latent herpesvirus-6 in salivary and bronchial glands. Lancet 1990; 336:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995; 92:7440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994; 169:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crawford JR, Santi MR, Thorarinsdottir HK, et al. Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol 2009; 46:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crawford JR, Santi MR, Cornelison R, et al. Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors. J Neurooncol 2009; 95:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kondo K, Kondo T, Shimada K, et al. Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J Med Virol 2002; 67:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andre-Garnier E, Milpied N, Boutolleau D, et al. Reactivation of human herpesvirus 6 during ex vivo expansion of circulating CD34+ haematopoietic stem cells. J Gen Virol 2004; 85:3333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santoro F, Kennedy PE, Locatelli G, et al. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mori Y, Yang X, Akkapaiboon P, et al. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 2003; 77:4992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossen LS, Schack VR, Thuesen KKH, et al. CD46 Isoforms Influence the Mode of Entry by Human Herpesvirus 6A/B in T Cells. J Virol 2022; 96:e0155721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith A, Santoro F, Di Lullo G, et al. Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003; 102:2877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karp CL, Wysocka M, Wahl LM, et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whyte ML, Smith KA, Buchberger A, et al. The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45). J Virol 2021; 95:e0162820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang H, Serada S, Kawabata A, et al. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A 2013; 110:9096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang H, Mori Y. Determinants of Human CD134 Essential for Entry of Human Herpesvirus 6B. J Virol 2015; 89:10125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogawa H, Fujikura D, Namba H, et al. Nectin-2 Acts as a Viral Entry Mediated Molecule That Binds to Human Herpesvirus 6B Glycoprotein B. Viruses 2022; 14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poetranto AL, Wakata A, Tjan LH, et al. Human herpesvirus 6A U27 plays an essential role for the virus propagation. Microbiol Immunol 2020; 64:703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nacheva EP, Ward KN, Brazma D, et al. Human herpesvirus 6 integrates within telomeric regions as evidenced by five different chromosomal sites. J Med Virol 2008; 80:1952.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mori Y, Koike M, Moriishi E, et al. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 2008; 9:1728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lusso P, Gallo RC, DeRocco SE, Markham PD. CD4 is not the membrane receptor for HHV-6. Lancet 1989; 1:730.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Luca D, Katsafanas G, Schirmer EC, et al. The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology 1990; 175:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lusso P, Malnati M, De Maria A, et al. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991; 147:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh N. Interactions between viruses in transplant recipients. Clin Infect Dis 2005; 40:430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagasaka M, Morioka I, Kawabata A, et al. Comprehensive analysis of serum cytokines/chemokines in febrile children with primary human herpes virus-6B infection. J Infect Chemother 2016; 22:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta S, Agrawal S, Gollapudi S. Differential effect of human herpesvirus 6A on cell division and apoptosis among naive and central and effector memory CD4+ and CD8+ T-cell subsets. J Virol 2009; 83:5442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takemoto M, Imasawa T, Yamanishi K, Mori Y. Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology 2009; 385:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tai AK, Luka J, Ablashi D, Huber BT. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 2009; 46:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996; 97:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gompels UA, Nicholas J, Lawrence G, et al. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 1995; 209:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindquester GJ, Inoue N, Allen RD, et al. Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome. Arch Virol 1996; 141:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang B, Nishimura M, Tang H, et al. Crystal Structure of Human Herpesvirus 6B Tegument Protein U14. PLoS Pathog 2016; 12:e1005594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallaschek N, Gravel A, Flamand L, Kaufer BB. The putative U94 integrase is dispensable for human herpesvirus 6 (HHV-6) chromosomal integration. J Gen Virol 2016; 97:1899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trempe F, Gravel A, Dubuc I, et al. Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins. Nucleic Acids Res 2015; 43:6084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mori J, Tang H, Kawabata A, et al. Human Herpesvirus 6A U14 Is Important for Virus Maturation. J Virol 2015; 90:1677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahmoud NF, Kawabata A, Tang H, et al. Human herpesvirus 6 U11 protein is critical for virus infection. Virology 2016; 489:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang T, Jia J, Garbarino E, et al. Human Herpesvirus 6A U4 Inhibits Proteasomal Degradation of the Amyloid Precursor Protein. J Virol 2022; 96:e0168821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sultanova A, Cistjakovs M, Sokolovska L, et al. Investigation of the Involvement of HHV-6 Encoded Viral Chemokine Receptors in Autoimmune Thyroiditis Development. Microbiol Spectr 2022; 10:e0236921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahmoud NF, Jasirwan C, Kanemoto S, et al. Cytoplasmic tail domain of glycoprotein B is essential for HHV-6 infection. Virology 2016; 490:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pfeiffer B, Berneman ZN, Neipel F, et al. Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies. J Virol 1993; 67:4611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horvat RT, Wood C, Balachandran N. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol 1989; 63:970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lusso P, Ensoli B, Markham PD, et al. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 1989; 337:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lusso P, Malnati MS, Garzino-Demo A, et al. Infection of natural killer cells by human herpesvirus 6. Nature 1993; 362:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greninger AL, Knudsen GM, Roychoudhury P, et al. Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6. BMC Genomics 2018; 19:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ranger S, Patillaud S, Denis F, et al. Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the world. J Med Virol 1991; 34:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990; 335:1047.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown NA, Sumaya CV, Liu CR, et al. Fall in human herpesvirus 6 seropositivity with age. Lancet 1988; 2:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352:768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dewhurst S, McIntyre K, Schnabel K, Hall CB. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol 1993; 31:416.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kasolo FC, Mpabalwani E, Gompels UA. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 1997; 78 ( Pt 4):847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knox KK, Carrigan DR. Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Caserta MT, Schnabel KC, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998; 26:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Bolle L, Van Loon J, De Clercq E, Naesens L. Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 2005; 75:76.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Human herpesvirus 6 iIncluding roseola) and 7. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31st ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL, 2018. p.454.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wyatt LS, Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 1992; 66:3206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Luca D, Mirandola P, Ravaioli T, et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995; 45:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pereira CM, Gasparetto PF, Corrêa ME, et al. Human herpesvirus 6 in oral fluids from healthy individuals. Arch Oral Biol 2004; 49:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roush KS, Domiati-Saad RK, Margraf LR, et al. Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am J Clin Pathol 2001; 116:648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baillargeon J, Piper J, Leach CT. Epidemiology of human herpesvirus 6 (HHV-6) infection in pregnant and nonpregnant women. J Clin Virol 2000; 16:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dahl H, Fjaertoft G, Norsted T, et al. Reactivation of human herpesvirus 6 during pregnancy. J Infect Dis 1999; 180:2035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Caserta MT, Schnabel KC, et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 2004; 145:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aubin JT, Poirel L, Agut H, et al. Intrauterine transmission of human herpesvirus 6. Lancet 1992; 340:482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashshi AM, Cooper RJ, Klapper PE, et al. Detection of human herpes virus 6 DNA in fetal hydrops. Lancet 2000; 355:1519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asano Y, Yoshikawa T, Suga S, et al. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990; 335:862.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8302 Version 19.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2876520" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3627265" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : HBLV (or HHV-6) in human cell lines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3627265" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : HBLV (or HHV-6) in human cell lines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3627265" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : HBLV (or HHV-6) in human cell lines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1653487" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8388398" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Antigenic and genetic differentiation of the two putative types of human herpes virus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1326815" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18461623" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Variability of gB and gH genes of human herpesvirus-6 among clinical specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8896242" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Growth of human herpesvirus 6 in HEPG2 cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8289346" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8551599" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Infection of primary human fetal astrocytes by human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2178187" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Isolation of human herpesvirus-6 from clinical specimens using human fibroblast cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1321861" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8388889" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1646280" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Latent human herpesvirus 6 infection of human monocytes/macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2156361" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Human herpesvirus 6 infection in renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1978098" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Latent herpesvirus-6 in salivary and bronchial glands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7638210" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8133119" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Human herpesvirus 6 infection in normal human brain tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19505845" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19424665" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12116029" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15483248" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Reactivation of human herpesvirus 6 during ex vivo expansion of circulating CD34+ haematopoietic stem cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10619434" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : CD46 is a cellular receptor for human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12663806" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35019717" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : CD46 Isoforms Influence the Mode of Entry by Human Herpesvirus 6A/B in T Cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12829600" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Selective suppression of IL-12 production by human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8662504" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Mechanism of suppression of cell-mediated immunity by measles virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33952641" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23674671" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : CD134 is a cellular receptor specific for human herpesvirus-6B entry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26202244" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Determinants of Human CD134 Essential for Entry of Human Herpesvirus 6B.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35062364" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Nectin-2 Acts as a Viral Entry Mediated Molecule That Binds to Human Herpesvirus 6B Glycoprotein B.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32827324" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Human herpesvirus 6A U27 plays an essential role for the virus propagation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18814270" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Human herpesvirus 6 integrates within telomeric regions as evidenced by five different chromosomal sites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18637904" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2564543" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : CD4 is not the membrane receptor for HHV-6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2155509" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The replication of viral and cellular DNA in human herpesvirus 6-infected cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1677024" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15668868" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Interactions between viruses in transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27346377" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Comprehensive analysis of serum cytokines/chemokines in febrile children with primary human herpes virus-6B infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19297473" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Differential effect of human herpesvirus 6A on cell division and apoptosis among naive and central and effector memory CD4+ and CD8+ T-cell subsets.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19144370" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19505843" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : HHV-6A infection induces expression of HERV-K18-encoded superantigen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8617868" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8035839" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Human herpesvirus-6 infection in children. A prospective study of complications and reactivation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7747482" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8634027" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27152739" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Crystal Structure of Human Herpesvirus 6B Tegument Protein U14.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27170009" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The putative U94 integrase is dispensable for human herpesvirus 6 (HHV-6) chromosomal integration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25999342" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26559847" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Human Herpesvirus 6A U14 Is Important for Virus Maturation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26761397" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Human herpesvirus 6 U11 protein is critical for virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34878807" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Human Herpesvirus 6A U4 Inhibits Proteasomal Degradation of the Amyloid Precursor Protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35604160" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Investigation of the Involvement of HHV-6 Encoded Viral Chemokine Receptors in Autoimmune Thyroiditis Development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26802210" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Cytoplasmic tail domain of glycoprotein B is essential for HHV-6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7687301" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2911127" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2463490" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7681936" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Infection of natural killer cells by human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29554870" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1655969" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the world.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1970369" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2542358" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Seroepidemiology of human herpesvirus 6 infection in normal children and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2899799" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Fall in human herpesvirus 6 seropositivity with age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15728809" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : A population-based study of primary human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8381815" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9129658" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8601223" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9455521" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15543581" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Quantitative analysis of human herpesvirus 6 cell tropism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15543581" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Quantitative analysis of human herpesvirus 6 cell tropism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1348548" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Human herpesvirus 7 is a constitutive inhabitant of adult human saliva.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7666047" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15485647" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Human herpesvirus 6 in oral fluids from healthy individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11710680" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10738135" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Epidemiology of human herpesvirus 6 (HHV-6) infection in pregnant and nonpregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10558965" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Reactivation of human herpesvirus 6 during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15480369" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1354806" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Intrauterine transmission of human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10801177" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Detection of human herpes virus 6 DNA in fetal hydrops.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1969592" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
